Welcome to LookChem.com Sign In|Join Free
  • or
N-{[(1R,2S,3R,4R)-4-(tert-butoxymethyl)-2,3-(isopropylidenedioxy)cyclopentyl]-aminocarbonyl}-3-methoxy-2-propenamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1070967-49-5

Post Buying Request

1070967-49-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1070967-49-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1070967-49-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,0,9,6 and 7 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1070967-49:
(9*1)+(8*0)+(7*7)+(6*0)+(5*9)+(4*6)+(3*7)+(2*4)+(1*9)=165
165 % 10 = 5
So 1070967-49-5 is a valid CAS Registry Number.

1070967-49-5Downstream Products

1070967-49-5Relevant academic research and scientific papers

(-)-Carbodine: Enantiomeric synthesis and in vitro antiviral activity against various strains of influenza virus including H5N1 (avian influenza) and novel 2009 H1N1 (swine flu)

Rao, Jagadeeshwar R.,Jha, Ashok K.,Rawal, Ravindra K.,Sharon, Ashoke,Day, Craig W.,Barnard, Dale L.,Smee, Donald F.,Chu, Chung K.

, p. 2601 - 2604 (2010)

Enantiomerically pure cyclopentyl cytosine [(-)-carbodine 1] was synthesized from d-ribose and evaluated for its anti-influenza activity in vitro in comparison to the (+)-carbodine, (±)-carbodine and ribavirin. (-)-Carbodine 1 exhibited potent antiviral activity against various strains of influenza A and B viruses.

Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation

-

Page/Page column 164, (2018/11/10)

The disclosed invention is a composition for and a method of seating a Flaviviridae (including BVDV and HCV), Orthomyxoviridae (including Influenza A and B) or Paramyxoviridae (including RSV) infection, or conditions related to abnormal cellular proliferation, in a host, including animals, and especially humans, using a nucleoside of general formula (I)-(XXIII) or its pharmaceutically acceptable salt or prodrug. This invention also provides an effective process to quantify the viral load, and in particular BVDV, HCV or West Nile Virus load, in a host, using real-time polymerase chain reaction (“RT-PCR”). Additionally, the invention discloses probe molecules that can fluoresce proportionally to the amount of virus present in a sample.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1070967-49-5